Systemic Toxicity of Intraperitoneal Vancomycin

Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Teerath Kumar, Iris Teo, Brendan B. McCormick
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2016/3968690
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554419741261824
author Teerath Kumar
Iris Teo
Brendan B. McCormick
author_facet Teerath Kumar
Iris Teo
Brendan B. McCormick
author_sort Teerath Kumar
collection DOAJ
description Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patient who developed a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after three weeks of intraperitoneal vancomycin. We review the literature and conclude that this is the first ever reported case of DRESS syndrome from intraperitoneal vancomycin.
format Article
id doaj-art-561439bfa1e04762962c1c8acfc880d9
institution Kabale University
issn 2090-6641
2090-665X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Nephrology
spelling doaj-art-561439bfa1e04762962c1c8acfc880d92025-02-03T05:51:31ZengWileyCase Reports in Nephrology2090-66412090-665X2016-01-01201610.1155/2016/39686903968690Systemic Toxicity of Intraperitoneal VancomycinTeerath Kumar0Iris Teo1Brendan B. McCormick2Division of Nephrology, Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, CanadaDepartment of Pathology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, CanadaDivision of Nephrology, Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, CanadaIntraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patient who developed a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after three weeks of intraperitoneal vancomycin. We review the literature and conclude that this is the first ever reported case of DRESS syndrome from intraperitoneal vancomycin.http://dx.doi.org/10.1155/2016/3968690
spellingShingle Teerath Kumar
Iris Teo
Brendan B. McCormick
Systemic Toxicity of Intraperitoneal Vancomycin
Case Reports in Nephrology
title Systemic Toxicity of Intraperitoneal Vancomycin
title_full Systemic Toxicity of Intraperitoneal Vancomycin
title_fullStr Systemic Toxicity of Intraperitoneal Vancomycin
title_full_unstemmed Systemic Toxicity of Intraperitoneal Vancomycin
title_short Systemic Toxicity of Intraperitoneal Vancomycin
title_sort systemic toxicity of intraperitoneal vancomycin
url http://dx.doi.org/10.1155/2016/3968690
work_keys_str_mv AT teerathkumar systemictoxicityofintraperitonealvancomycin
AT iristeo systemictoxicityofintraperitonealvancomycin
AT brendanbmccormick systemictoxicityofintraperitonealvancomycin